TABLE 4.
Deficiency mapping of autosomal QTL affecting sternopleural bristle number
| Both sexes
|
Females
|
Males
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deficiency | P(L × G) | P(L × G × S) | Var(Df) | Var(Bal) | P(L × G) | Var(Df) | Var(Bal) | P(L × G) | Var(Df) | Var(Bal) | QTL | Sex |
| Df(2L)al | 0.000 | 0.343 | 13.99 | 6.93 | 0.001 | 9.59 | 4.44 | 0.004 | 21.90 | 10.80 | 21B8–C1;21C8–D1 | B |
| Df(2L)ast2 | 0.003 | 0.119 | 2.73 | 4.33 | 0.008 | 2.14 | 2.95 | 0.388 | 5.24 | 6.49 | 21D1–2;22A2–3 | B |
| Df(2L)C144 | 0.045 | 0.179 | 5.10 | 5.42 | 0.523 | 2.93 | 4.13 | 0.008 | 8.39 | 7.61 | 23A1–2;23C3–5 | M |
| Df(2L)XE-2750 | 0.014 | 0.091 | 6.00 | 3.27 | 0.374 | 3.20 | 2.04 | 0.002 | 11.87 | 5.35 | 28C;28D3 | M |
| Df(2L)TE29Aa-11 | 0.591 | 0.000 | 3.22 | 2.73 | 0.466 | 1.54 | 1.63 | 0.015 | 8.24 | 4.71 | 28E4–7;29B2–C1 | M |
| Df(2L)r10 | 0.493 | 0.544 | 10.61 | 9.85 | 0.967 | 7.23 | 7.19 | 0.047 | 16.05 | 13.28 | 35F1–7;36A8–9 | M |
| Df(2L)TW161 | 0.063 | 0.439 | 6.81 | 5.59 | 0.041 | 4.32 | 3.55 | 0.440 | 10.94 | 8.92 | 38A6–B1;40A4–B1 | F |
| Df(2R)M41A4 | 0.000 | 0.002 | 13.65 | 6.70 | 0.000 | 12.36 | 3.67 | 0.335 | 17.60 | 12.73 | 41A | F |
| In(2LR)Gla | 0.028 | 0.149 | 7.49 | 9.47 | 0.239 | 5.65 | 5.88 | 0.034 | 10.36 | 15.07 | 41B;42A2–3 | B |
| Df(2R)cn9 | 0.001 | 0.473 | 13.94 | 7.76 | 0.124 | 8.85 | 5.08 | 0.008 | 22.24 | 12.43 | 43E15–18;43F | B |
| Df(2R)Np5 | 0.000 | 0.372 | 12.37 | 4.60 | 0.000 | 8.95 | 3.02 | 0.003 | 17.13 | 7.82 | 44F12;45A6–7 | B |
| Df(2R)w45-30n | 0.011 | 0.296 | 8.39 | 4.83 | 0.264 | 4.86 | 2.81 | 0.003 | 14.09 | 8.56 | 45D9–E1;45E2–3 | M |
| Df(2R)stan1 | 0.000 | 0.027 | 6.94 | 4.06 | 0.005 | 6.64 | 3.66 | 0.000 | 7.21 | 5.39 | 47A1;47D3 | B |
| Df(2R)P34 | 0.008 | 0.001 | 15.19 | 8.42 | 0.114 | 5.61 | 3.65 | 0.002 | 42.87 | 23.00 | 55F;56C1–11 | M |
| Df(2R)017 | 0.000 | 0.263 | 14.55 | 9.46 | 0.006 | 11.98 | 8.24 | 0.002 | 18.78 | 11.10 | 56F9–15 | B |
| Df(2R)Egfr5 | 0.003 | 0.363 | 6.29 | 5.11 | 0.028 | 3.88 | 3.74 | 0.085 | 10.27 | 7.32 | 57D11–12;58D1 | B |
| Df(2R)59AD | 0.010 | 0.641 | 11.10 | 4.95 | 0.026 | 8.44 | 4.09 | 0.082 | 14.78 | 6.49 | 59A1–3;59D1–4 | B |
| Df(3L)AC1 | 0.320 | 0.390 | 6.27 | 4.72 | 0.955 | 3.90 | 3.21 | 0.021 | 10.54 | 6.56 | 67B1;67D7–13 | M |
| Df(3L)lxd6 | 0.002 | 0.546 | 3.10 | 5.59 | 0.810 | 1.67 | 3.01 | 0.002 | 6.13 | 9.47 | 67E1–2;67F2–3 | B |
| Df(3L)brm11 | 0.000 | 0.336 | 8.75 | 3.47 | 0.005 | 4.83 | 1.91 | 0.002 | 16.03 | 6.26 | 72C1;72D10 | B |
| Df(3L)st-f13 | 0.000 | 0.067 | 9.43 | 2.78 | 0.010 | 5.77 | 2.12 | 0.000 | 15.20 | 3.70 | 72C1;72D10 | B |
| Df(3l)ri-79c | 0.017 | 0.942 | 8.37 | 4.06 | 0.048 | 5.47 | 2.64 | 0.223 | 11.43 | 7.08 | 77D1;77F–78A | B |
| Df(3R)Dfd13 | 0.028 | 0.594 | 6.87 | 4.97 | 0.019 | 4.97 | 3.34 | 0.220 | 9.54 | 7.68 | 83E3;84A1–2 | B |
| Df(3R)Scr | 0.036 | 0.578 | 10.10 | 7.11 | 0.085 | 8.64 | 5.38 | 0.306 | 11.99 | 9.14 | 84A4–5;84B1–2 | B |
| Df(3R)Antp17 | 0.063 | 0.098 | 10.81 | 6.56 | 0.300 | 9.30 | 4.42 | 0.011 | 13.06 | 10.73 | 84B1–2;84D3–5 | M |
| Df(3R)p-XT103 | 0.001 | 0.006 | 6.18 | 8.96 | 0.005 | 7.42 | 7.24 | 0.000 | 6.03 | 12.92 | 85A2;85C1–2 | B |
| Df(3R)M-Kx | 0.016 | 0.780 | 4.04 | 5.29 | 0.022 | 2.56 | 4.68 | 0.744 | 5.97 | 6.22 | 86C1;86E2–4 | B |
| Df(3R)P14 | 0.000 | 0.434 | 42.24 | 7.20 | 0.000 | 31.43 | 5.32 | 0.000 | 56.48 | 9.80 | 90C2–D1;91A1–2 | B |
| Df(3R)mbc-R1 | 0.174 | 0.037 | 4.90 | 3.13 | 0.034 | 3.59 | 2.08 | 0.126 | 6.84 | 5.19 | 95A5–7;95D6–11 | F |
| Df(3R)3450 | 0.042 | 0.485 | 12.02 | 4.59 | 0.018 | 8.52 | 1.81 | 0.496 | 16.09 | 10.49 | 98E3;99A1–2 | F |
| Df(3R)Dr-rv1 | 0.039 | 0.378 | 5.80 | 5.35 | 0.296 | 4.30 | 3.04 | 0.098 | 7.99 | 8.78 | 99A6–8;99B6–11 | B |
| Df(3R)tll-g | 0.025 | 0.632 | 9.72 | 6.66 | 0.024 | 6.49 | 4.62 | 0.236 | 14.61 | 9.89 | 99F1–2;100B4–5 | B |
| Df(3R)awd-KRB | 0.001 | 0.039 | 4.84 | 5.50 | 0.040 | 2.97 | 4.05 | 0.000 | 6.89 | 8.54 | 100C;100D | B |
P-values are from the line × genotype and line × genotype × sex terms in deficiency complementation ANOVAs. Var(Df) and Var(Bal) are among-line variance components for mutation-accumulation selection lines as hemizygotes against deficiencies and heterozygotes against balancer chromosomes, respectively.